Trueblood Wealth Management’s Freeport-McMoran FCX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$289K Buy
4,602
+222
+5% +$14.3K 0.1% 211
2026
Q1
$257K Buy
4,380
+10
+0.2% +$604 0.1% 222
2025
Q4
$222K Buy
+4,370
New +$189K 0.09% 238
2024
Q4
Sell
-4,835
Closed -$241K 231
2024
Q3
$241K Buy
4,835
+51
+1% +$2.3K 0.12% 197
2024
Q2
$233K Buy
4,784
+110
+2% +$5.54K 0.13% 198
2024
Q1
$220K Sell
4,674
-2,108
-31% -$85.1K 0.13% 205
2023
Q4
$289K Buy
+6,782
New +$250K 0.18% 158

Other funds holding FCX

Trueblood Wealth Management's FCX Position: Q2 2026 in Review

Trueblood Wealth Management increased its Freeport-McMoran (FCX) stake by 5.1% in Q2 2026, buying an estimated $14.3K and bringing the position to 4,602 shares worth $289K. The position accounts for 0.1% of the portfolio, ranked #211.

Trueblood Wealth Management first reported a position in FCX in Q4 2023 and has held it in 7 quarters since. 1,888 funds tracked by Wall St. Rank hold FCX as of Q2 2026.

  • Trueblood Wealth Management held 4,602 shares of Freeport-McMoran worth $289K as of Q2 2026.
  • Trueblood Wealth Management bought 222 Freeport-McMoran shares in Q2 2026, an estimated $14.3K.
  • Freeport-McMoran made up 0.1% of Trueblood Wealth Management's portfolio in Q2 2026, its #211 holding.
  • Trueblood Wealth Management first reported a position in Freeport-McMoran in Q4 2023 and has held it in 7 quarters since.
  • 1,888 funds tracked by Wall St. Rank held Freeport-McMoran as of Q2 2026.

Based on Trueblood Wealth Management's 13F filing for Q2 2026, filed 27 Jul 2026.